Medy-Tox Inc. (086900)

Overview

Medy-Tox Inc., headquartered in Cheongju, South Korea, stands out as a pioneering biopharmaceutical company with a foundation laid in the year 2000. The company has carved its niche in the global healthcare industry by focusing on the development, manufacturing, and commercialization of a wide range of innovative biopharmaceutical products. Known for its advanced research and development capabilities, Medy-Tox has made significant strides in biopharmaceuticals, particularly in the areas of botulinum toxin products and hyaluronic acid fillers. With a robust commitment to improving health and wellbeing across the globe, the company exports its high-quality products to approximately 60 countries, including Japan, Thailand, and Brazil. Furthermore, Medy-Tox has established strategic partnerships for expanding its research horizons and product offerings, notably partnering with Dyadic International, Inc. to develop vaccines against COVID-19 variants, showcasing its adaptability and forward-thinking approach in responding to global health crises.

Products and Services

• Neuronox
  

  A lyophilized white powder formulated for injection, Neuronox is primarily used in treating foot deformities caused by spasticity in pediatric cerebral palsy patients. This product exemplifies Medy-Tox's dedication to addressing neurological conditions through innovative biopharmaceutical solutions.

• INNOTOX
  

  INNOTOX is presented as a colorless transparent liquid-filled injection, designed for the temporary improvement of moderate to severe glabellar wrinkles. This product underscores the company's expertise in developing aesthetic medicine solutions aimed at enhancing patient self-esteem and quality of life.

• Coretox
  

  Coretox, similar to Neuronox, is a lyophilized white powder for injection, but it specifically targets the temporary improvement of moderate to severe glabellar wrinkles. Through Coretox, Medy-Tox further solidifies its position in the cosmetic medicine industry by providing effective and reliable anti-wrinkle treatments.

• Hyaluronic Acid Filler Products
  

  The company's portfolio includes Neuramis and Potenfill, hyaluronic acid filler products that illustrate Medy-Tox's commitment to pioneering tissue recovering biomaterials. These fillers are designed for cosmetic enhancements, demonstrating an advanced understanding of aesthetic needs and innovative solutions.

• Medical Devices
  

  Medy-Tox also ventures into the medical device realm with products like ComfortDual and Recell Ice for tissue coagulation using high-frequency current; Neurajet Plus for assisted injections of pharmaceuticals; Carewave for improving erectile dysfunction through low-intensity shock wave therapy; and Careveam for treating skin ailments with ultraviolet light. These offerings highlight the company's versatility and innovative spirit in developing medical devices that cater to a range of therapeutic and aesthetic needs.

• Neurakin cream
  

  Targeting various dermatological conditions, Neurakin cream is formulated for the treatment of acute eczema, contact dermatitis, atopic dermatitis, chronic eczema, rosacea dermatitis, perioral dermatitis, herpes zoster, and acne vulgaris. This product manifests Medy-Tox's holistic approach to healthcare, addressing both common and complex skin conditions.